Cargando…
Tamoxifen Decreases Lithium-Induced Natriuresis in Rats With Nephrogenic Diabetes Insipidus
Lithium is widely used in the treatment of bipolar affective disorders, but often causes nephrogenic diabetes insipidus (NDI), a condition characterized by a severe urinary concentrating defect. Lithium-induced NDI is associated with dysregulation of the amiloride-sensitive epithelial sodium channel...
Autores principales: | Tingskov, Stine Julie, Kwon, Tae-Hwan, Frøkiær, Jørgen, Nørregaard, Rikke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052323/ https://www.ncbi.nlm.nih.gov/pubmed/30050465 http://dx.doi.org/10.3389/fphys.2018.00903 |
Ejemplares similares
-
Vasopressin-Independent Regulation of Aquaporin-2 by Tamoxifen in Kidney Collecting Ducts
por: Tingskov, Stine Julie, et al.
Publicado: (2019) -
Dysregulation of Renal Cyclooxygenase-2 in Rats with Lithium-induced Nephrogenic Diabetes Insipidus
por: Kwon, Tae-Hwan
Publicado: (2007) -
Tamoxifen Affects Aquaporin-3 Expression and Subcellular Localization in Rat and Human Renal Collecting Ducts
por: Tingskov, Stine Julie, et al.
Publicado: (2023) -
Activation of the prostaglandin E(2) EP(2) receptor attenuates renal fibrosis in unilateral ureteral obstructed mice and human kidney slices
por: Jensen, Michael Schou, et al.
Publicado: (2019) -
Absence of PKC-Alpha Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus
por: Sim, Jae H., et al.
Publicado: (2014)